- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06346171
VR Augmented Human Delivered Integrative Psychotherapy for Colonoscopy Procedural Anxiety and Pain (VRIPanx-COL)
Evaluating a Virtual Reality Augmented Clinician-Delivered Integrative Psychotherapy Model for Non-Sedated Colonoscopy Procedural Anxiety and Pain: A Prevalidation Trial Protocol (VRIPanx-COL)
Colonoscopy is an invaluable tool for the diagnosis and management of colon diseases, especially colorectal cancer (CRC) - the third most common cancer worldwide. Its unmatched ability to detect CRC and premalignant growths makes it the gold standard; however, it is not without its challenges. Patients often experience pre-procedure anxiety and discomfort primarily related to anticipated pain, which negatively impacts both the procedure and its outcomes.
Colonoscopy procedural anxiety not only exacerbates the experience of pain, but also may compromise the quality of bowel preparation, augment procedure and recovery room times, and increase the use of sedation, particularly among females, who report greater pre-procedural anxiety, and perceive the procedure to be more painful and harder to endure. This underscores the importance of interventions aimed at mitigating anxiety to improve patient experience and adherence to colonoscopy procedures.
The profound positive corelation between anxiety and pain impact on outcomes of colonoscopy warrants an investigation of comprehensive patient care strategies. A growing body of evidence indicates that non-pharmacologic interventions, such as music therapy and immersive virtual reality (iVR), may effectively reduce anxiety, pain, and enhance overall patient satisfaction.
Understanding barriers to colonoscopy compliance, such as fear of cancer diagnosis, the perception of invasiveness, and feelings of embarrassment is paramount to enhancing CRC screening uptake, therefore lowering mortality.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed VR-Facilitated Integrative Psychotherapy framework (VRIPainX-COL) leverages the immersive capabilities of VR as platform fir psychological interventions for this pilot trial is designed to assess its preliminary efficacy, acceptability, and feasibility in reducing the pre-procedural anxiety and discomfort associated with colonoscopy.
Primary Aims:
1.1 Developing a comprehensive conceptual framework for colonoscopy procedural anxiety and pain reduction through a a humanised digital interface using virtual reality distraction as platform for integrative psychotherapy support VRIPanx-COL; 1.2 Clinically implementing the VRIPanx-COL blueprint within a methodological design aimed at assessing its preliminary efficacy in reducing perceived procedural anxiety and pain compared to 1.3 VR distraction alone and 1.4 conventional non-sedated colonoscopy
Secondary Aims:
2.1 Evaluate the feasibility and acceptability of implementing VRIP-Col interventions during non-sedated colonoscopy, 2.2 Gathering qualitative feedback from both patients and performing colonoscopists regarding VRIP experienced advantages, obstacles and their perspectives for enhancing the intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marcel A Gaina, ass.prof. MD
- Phone Number: 0040 756901749
- Email: marcel-alexandru_t_gaina@d.umfiasi.ro
Study Contact Backup
- Name: Gheorghe G Balan, Attd.prof.MD
- Phone Number: 0040 744518195
- Email: gheorghe-g-balan@umfiasi.ro
Study Locations
-
-
Iasi
-
Iaşi, Iasi, Romania, 700115
- University of Medicine and Pharmacy Grigore T Popa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- scheduled non-sedated colonoscopy.
- cognitive ability to understand study aims;
- willingness to participate and provide written consent.
Exclusion criteria:
- emergency colonoscopy;
- significant sensory-cognitive impairments;
potential risk of:
- photic seizures;
- photosensitivity;
- severe motion sickness;
- allergies to materials used.
anxiety disorders:
- use of psychoactive or analgesic substances;
- concomitant psychotherapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality Integrative Psychotherapy
This group will undergo the same virtual reality exposure software during the colonoscopy procedure, but the psychotherapist will implement the integrative psychotherapy framework during the procedure.
|
Music therapy: "Weightless" by Marconi Union plays continuously, bridging VR distraction and psychotherapy. Before: Patients pick a VR scene (-13 to -10 min), learn VR navigation, and practice 4-7-8 breathing with a VR flower for grounding and resilience (-10 to -9 min). They continue 4-7-8 doing Progressive Muscle Relaxation (4+7 contraction, 8 relaxation), moving from lower body to facial muscles (-8 to -5 min). Values and commitment to action are discussed (-4 to -2 min), emphasizing present-focused thoughts and acceptance (-1 min). During: Mindfulness and relaxation are encouraged, with PMR during intense moments. Empowerment and procedural feedback are provided (0 to 30/45 min). After: Debriefing normalizes the experience, reinforcing proactive health actions (35 to 50 min).
Other Names:
Software: Nature Treks VR nature environments. Hardware: dedicated head-mounted VR display (Oculus Rift S.) powered by a high-end computer (Laptop with at least GTX 1080 graphics card, both with processing units that lower the bottleneck chances); minimum specifications should facilitate presence while limiting cybersickness by ensuring refresh rates beyound 85 frames/second. Music therapy: "Weightless" by Marconi Union plays continuously, facilitating sensorial distraction while also allowing blinding. Although the psychotherapist will interact with the patient, the dialogue will exclude psychotherapic approaches. The dialogue is designed to be neutral, resembling a comprehensive tutorial for the VR experience. This serves as a comparator to assess the added value of integrating psychotherapeutic techniques within the VR experience.
Other Names:
|
Sham Comparator: Virtual Reality Distraction
This group will be exposed to the virtual reality environment as a distraction, but although receiving support in exploring the virtual world, no psychotherapy techniques will implemented.
|
Software: Nature Treks VR nature environments. Hardware: dedicated head-mounted VR display (Oculus Rift S.) powered by a high-end computer (Laptop with at least GTX 1080 graphics card, both with processing units that lower the bottleneck chances); minimum specifications should facilitate presence while limiting cybersickness by ensuring refresh rates beyound 85 frames/second. Music therapy: "Weightless" by Marconi Union plays continuously, facilitating sensorial distraction while also allowing blinding. Although the psychotherapist will interact with the patient, the dialogue will exclude psychotherapic approaches. The dialogue is designed to be neutral, resembling a comprehensive tutorial for the VR experience. This serves as a comparator to assess the added value of integrating psychotherapeutic techniques within the VR experience.
Other Names:
|
No Intervention: Control group
This group will undergo treatment as usual according to state-of-the-art guidelines for non-sedated colonoscopy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction in Procedure-Related Anxiety
Time Frame: STAY-Y1: baseline anxiety measured within 20 minutes before the procedure; post-procedural anxiety (within 20 minutes after the procedure's completion).
|
This measure assesses the degree of reduction in anxiety related to undergoing a non-sedated colonoscopy procedure.
Anxiety levels will be quantified using the Spielberger STAI-Y1 and STAI-Y2 forms, previously standardized to the Romanian population and approved by Romanian Psychological College.
STAI-Y1 and Y2 are applied and interpreted by a licensed investigator, in order to ensure viability of collected data.
The scale measures how respondents feel at a particular moment in time and in general, providing insight into both state and trait anxiety levels.
The difference in STAI-Y1 scores from baseline (pre-intervention) to post-procedure will be analyzed to determine the effectiveness of the VR-Augmented Integrative Psychotherapy in reducing procedural anxiety compared to Sham VR Distraction and control groups.
|
STAY-Y1: baseline anxiety measured within 20 minutes before the procedure; post-procedural anxiety (within 20 minutes after the procedure's completion).
|
Pain perception
Time Frame: Within 20 minutes before the colonoscopy procedure (baseline) and immediately after the procedure (within 20 minutes post-procedure).
|
The primary measure of pain perception will be the Visual Analog Scale (VAS), a validated tool for pain assessment.
This self-reported measure allows patients to rate their pain on a scale from "no pain" (0) to "worst imaginable pain" (10).
|
Within 20 minutes before the colonoscopy procedure (baseline) and immediately after the procedure (within 20 minutes post-procedure).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Qualitative Feedback on VRIP-Col Interventions
Time Frame: Data on feasibility and acceptability will be collected within 24 hours after the colonoscopy procedure.
|
This outcome will involve the collection and analysis of qualitative feedback from patients who receive the VRIP-Col interventions and the colonoscopists who perform the procedures.
Feedback will be gathered through semi-structured interviews designed to explore the perceived advantages of the VRIP-Col interventions, any obstacles encountered during their implementation, and suggestions for improvement from both the patient and provider perspectives.
This qualitative analysis will provide insights into the user experience, identify potential barriers to effective implementation, and inform future refinements of the VRIP-Col approach.
|
Data on feasibility and acceptability will be collected within 24 hours after the colonoscopy procedure.
|
Feasibility and Acceptability of VRIP-Col Interventions
Time Frame: Data on feasibility and acceptability will be collected within 24 hours after the colonoscopy procedure.
|
This outcome will assess the logistical feasibility and overall acceptability of the VRIP-Col interventions among patients undergoing non-sedated colonoscopy.
Feasibility metrics will include the successful integration of VRIP-Col into clinical workflows, the ability to deliver the intervention to all enrolled participants without disrupting standard care procedures, and the technical reliability of VR equipment.
Acceptability will be evaluated through patient and healthcare provider satisfaction surveys, focusing on the perceived usefulness, ease of use, and willingness to use or recommend the VRIP-Col interventions in the future.
|
Data on feasibility and acceptability will be collected within 24 hours after the colonoscopy procedure.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trait anxiety
Time Frame: Within 72 hours after study enrolment.
|
STAI-Y2 will reveal the participants general anxiety in order for a more relevant group matching.
Participants general tendency to perceive and respond to situations as threatening or anxiety-inducing.
It will be applied after enrolling.
|
Within 72 hours after study enrolment.
|
Quality of Life impact VRIP-Col
Time Frame: Within 36 hours before and after the colonoscopy procedure.
|
Assessment of the bio-psycho-social interplay of VRIP as reflected by the score dynamic of the Health, Self-Esteem, relationships and Goals and Values items assessed by a qualified researcher using a Romanian population-standardised Quality of Life Inventory.
|
Within 36 hours before and after the colonoscopy procedure.
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Marcel A Gaina, ass.prof. MD, University of Medicine and Pharmacy "Grigore T Popa" Iasi, Romania
- Study Chair: Cristinel Stefanescu, Prof. MD, University of Medicine and Pharmacy "Grigore T Popa" Iasi, Romania
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 408/06.03.2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Procedural Pain
-
IRCCS Burlo GarofoloCompletedProcedural Pain ReliefItaly
-
Defense and Veterans Center for Integrative Pain...DepomedCompletedMinor Procedural PainUnited States
-
IWK Health CentreCompletedNeonatal Procedural Pain ResponseCanada
-
Beth Israel Deaconess Medical CenterRecruitingProcedural Pain | Pain Catastrophizing | Procedural AnxietyUnited States
-
University of UtahCompleted
-
University Hospital, BrestCompletedPrevention of the Procedural Pain in the NewbornFrance
-
Hamad Medical CorporationRecruitingProcedural Pain | Procedural AnxietyQatar
-
Nationwide Children's HospitalEnrolling by invitationProcedural Pain | Procedural AnxietyUnited States
-
Central Hospital, Nancy, FranceUnknownVirtual Reality | Procedural Pain | Procedural AnxietyFrance
-
Brooke Army Medical CenterRecruitingPerioperative Care | Procedural Pain | Procedural AnxietyUnited States
Clinical Trials on Virtual Reality Integrative Psychotherapy
-
University of Illinois at Urbana-ChampaignNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern... and other collaboratorsNot yet recruitingDepressive Symptoms | End Stage Kidney Disease
-
Consorci Hospitalari de VicActive, not recruiting
-
Mental Health Services in the Capital Region, DenmarkMental Health Services in the Region of Southern Denmark; Mental Health Services...Active, not recruitingAuditory HallucinationsDenmark
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Technical University of MunichGerman Center for Vertigo and Balance DisordersUnknownSomatoform Vertigo/Dizziness
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongRecruiting
-
Universidad Rey Juan CarlosCompleted
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
National University of MalaysiaRecruitingPleural EffusionMalaysia